L3Harris's 'trusted disruptor' pivot: delay the missile IPO, double down on wartime capacity
The company raises 2026 EPS guidance, signs a $12B missile framework, and pushes the missile IPO to mid-2027 to bankroll an aggressive capacity build at a 'wartime footing.'
LHX · Earnings Call · 2026-07-29
A deliberate bet on speed and scale
L3Harris's second-quarter call was less about a beat-and-raise and more about a strategic declaration: the company is all-in on munitions, willing to delay a hotly anticipated IPO to fund what CEO Christopher Kubasik calls a wartime footing. Orders reached $7.3 billion (book-to-bill 1.2x), backlog rose above $42 billion, and the company lifted full-year EPS guidance by $0.40 to a range of $11.80–$12.00. The headline, however, was the decision to slide the missile business IPO to mid-2027. "Market conditions have evolved and do not reflect the tremendous value we are building," Kubasik said, “With capacity expansion underway and the momentum accelerating, we are poised to deliver even greater value as we ramp production to support our nation's urgent and critical needs.” — Christopher E. Kubasik, Chairman and CEO · 2026-07-29 The logic is straightforward: the Department of War's $1 billion investment plus a new $12 billion framework agreement for THAAD and PAC-3 production give the company multiyear visibility they wouldn't get from an IPO today. CFO Kenneth Sharp framed the framework as a structural accelerant: "We signed a framework agreement for 7 years of THAAD and PAC-3 production representing approximately $12 billion of future production revenue and $2 billion of future profit," he noted, “Orders were $7.3 billion, yielding a book-to-bill of 1.2x. Our trailing 12-month book-to-bill was 1.3x.” — Kenneth Sharp, Chief Financial Officer · 2026-07-29 The margin profile on that work is expected to land in the mid-teens; Kubasik told analysts to expect something in the "15%, 17%, 18% range" on the framework, “especially as we ramp up with volume and get the supply chain lined up with longer term agreements.” — Christopher E. Kubasik, Chairman and CEO · 2026-07-29Financial firepower and a rising capital bill
Revenue grew 8% to $5.9 billion, with international sales up over 20% — a theme that's persisted for L3Harris and broadens across the sector. Capital expenditures jumped 68% year-over-year to $99M in Q1-26, reflecting the new GMLRS and PAC-3 factories, and the company has committed $2 billion in total missile capacity investments. The balance sheet supports the plan: operating cash flow was $879 million and free cash flow rose 37% to $771 million, while net leverage sits at 2.3x. The company also raised its segment margin outlook for Communications and Spectrum Dominance to mid-25%. This is not just a one-off. The momentum echoes prior calls where management flagged the demand signal for solid rocket motors and pressed on the need for multiyear commitments. Back in January, Kubasik told investors, "We were excited to hear this morning that Lockheed Martin reached an agreement on THAAD," “We're the only provider of the propulsion and DAC systems for THAAD.” — Christopher E. Kubasik, Chairman and Chief Executive Officer · 2026-01-29 By April, he described the framework as "a term sheet, if you will," “Those frameworks are in place... we are close to finalizing those frameworks as a subcontractor framework with a prime.” — Christopher E. Kubasik, Chairman and Chief Executive Officer · 2026-04-30 The delay of the IPO now turns a market-driven hesitation into a deliberate capital-mobilization move.Market context: a falling stock, a rising order book
The stock has been cut by a quarter over the past 90 days (down -24.6%), but this report's bullish signals sit on top of a broad defense build-out. All three segments grew revenue, and international dynamics — from NATO allies to the Middle East — continue to pull International sales higher. The key new keyword this quarter, "wartime footing," is a company-specific reframing of the macro demand, distinct from the sector's usual missile tracking chatter. It appears in no prior transcript for LHX, underscoring a deliberate strategic pivot rather than routine commentary. While the IPO delay might read as a concession to weak markets, management frames it as the opposite: more time to build scale, secure contracts, and let the cash from munitions flow. "We do not ask our investors to take our vision on faith," Kubasik said,The next 18 months will test whether the trusted disruptor can deliver on that promise, but today the company is spending like it already has the orders.We transformed and turned the operation around. We integrated ahead of plan, and then combined it with complementary L3Harris missile technologies creating a purpose-built missile solutions business.